These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D. Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [Abstract] [Full Text] [Related]
3. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R. Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280 [Abstract] [Full Text] [Related]
4. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. Jamerson KA, Nwose O, Jean-Louis L, Schofield L, Purkayastha D, Baron M. Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521 [Abstract] [Full Text] [Related]
5. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension. Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators. Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192 [Abstract] [Full Text] [Related]
6. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I. Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820 [Abstract] [Full Text] [Related]
7. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study]. Fan CM, Yan LR, Tao YK, Wang L, Li YQ, Gao MM, Wang YN, Li CX, Wang XW, Lu XL, Pang HM, Li YS. Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):57-60. PubMed ID: 21418799 [Abstract] [Full Text] [Related]
8. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F. Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006 [Abstract] [Full Text] [Related]
9. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial. Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y. Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480 [Abstract] [Full Text] [Related]
10. An eight-week, multicenter, randomized, double-blind study to evaluate the efficacy and tolerability of fixed-dose amlodipine/benazepril combination in comparison with amlodipine as first-line therapy in chinese patients with mild to moderate hypertension. Ueng KC, Lin LC, Voon WC, Lin MC, Liu YB, Su HM, Chang PY, Lin TH, Chen WL, Wu CC, Lai WT, Lin CS. Blood Press Suppl; 2008 Jun; 1():24-31. PubMed ID: 18705532 [Abstract] [Full Text] [Related]
11. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension. Germino FW. Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484 [Abstract] [Full Text] [Related]
12. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM. Oigman W, Gomes MA, Pereira-Barretto AC, Póvoa R, Kohlmann O, Rocha JC, Nobre F. Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755 [Abstract] [Full Text] [Related]
13. The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group. Wilson TW, Lacourcière Y, Barnes CC. CMAJ; 1998 Sep 08; 159(5):469-76. PubMed ID: 9757170 [Abstract] [Full Text] [Related]
14. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study. Shimada K, Ogihara T, Saruta T, Kuramoto K, REZALT Study Group. Clin Ther; 2010 May 08; 32(5):861-81. PubMed ID: 20685495 [Abstract] [Full Text] [Related]
15. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison. Lee HY, Kang HJ, Koo BK, Oh BH, Heung-Sun K, Kim KS, Seo HS, Ro YM, Kang JH, Woong CJ, Joo SJ, Kim MH, Joon-Han S, Yoon J, Park SH, Jin-Ok J, Ju AK, Chong-Yun R, Yeon KJ, Park KM, Lim DK, Park SY, Amostar Study Investigators. Clin Ther; 2005 Jun 08; 27(6):728-39. PubMed ID: 16117979 [Abstract] [Full Text] [Related]
16. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL). Tytus RH, Burgess ED, Assouline L, Vanjaka A. Clin Ther; 2007 Feb 08; 29(2):305-15. PubMed ID: 17472822 [Abstract] [Full Text] [Related]
17. Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. Fogari R, Zoppi A, Derosa G, Mugellini A, Lazzari P, Rinaldi A, Fogari E, Preti P. J Hum Hypertens; 2007 Mar 08; 21(3):220-4. PubMed ID: 17215848 [Abstract] [Full Text] [Related]
18. Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study. Kang SM, Youn JC, Chae SC, Park CG, Yang JY, Kim MH, Hong TJ, Kim CH, Kim JJ, Shin DG, Jeong JW, Yoon JH, Park SH, Kwon J, Cho SY. Clin Ther; 2011 Dec 08; 33(12):1953-63. PubMed ID: 22136978 [Abstract] [Full Text] [Related]
19. Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage II hypertension. Sharma A, Bagchi A, Kinagi SB, Sharma YK, Baliga VP, Bollmall C. Clin Ther; 2007 Dec 08; 29(12):2667-76. PubMed ID: 18201582 [Abstract] [Full Text] [Related]
20. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults. Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A. Clin Ther; 2007 Jan 08; 29(1):61-73. PubMed ID: 17379047 [Abstract] [Full Text] [Related] Page: [Next] [New Search]